The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Brucellosis


High impact information on Brucellosis


Chemical compound and disease context of Brucellosis


Biological context of Brucellosis


Anatomical context of Brucellosis


Gene context of Brucellosis


Analytical, diagnostic and therapeutic context of Brucellosis


  1. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Ko, J., Splitter, G.A. Clin. Microbiol. Rev. (2003) [Pubmed]
  2. Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization models. Van De Verg, L.L., Hartman, A.B., Bhattacharjee, A.K., Tall, B.D., Yuan, L., Sasala, K., Hadfield, T.L., Zollinger, W.D., Hoover, D.L., Warren, R.L. Infect. Immun. (1996) [Pubmed]
  3. False positive serological reactions in bovine brucellosis: evidence of the role of Yersinia enterocolitica serotype O:9 in a field trial. Gerbier, G., Garin-Bastuji, B., Pouillot, R., Véry, P., Cau, C., Berr, V., Dufour, B., Moutou, F. Vet. Res. (1997) [Pubmed]
  4. Brucellosis in sub-Saharan Africa: epidemiology, control and impact. McDermott, J.J., Arimi, S.M. Vet. Microbiol. (2002) [Pubmed]
  5. Tuberculosis and brucellosis prevalence survey on dairy cattle in Mbarara milk basin (Uganda). Bernard, F., Vincent, C., Matthieu, L., David, R., James, D. Prev. Vet. Med. (2005) [Pubmed]
  6. Cellular prion protein promotes Brucella infection into macrophages. Watarai, M., Kim, S., Erdenebaatar, J., Makino, S., Horiuchi, M., Shirahata, T., Sakaguchi, S., Katamine, S. J. Exp. Med. (2003) [Pubmed]
  7. Secondary amenorrhoea due to persistent corpus luteum in brucellosis. Geva, E., Gottesman, G., Lemer-Geva, L., Lang, R., Pomeranz, M., Barak, V., Wolach, B. Lancet (1995) [Pubmed]
  8. Diagnosis of human brucellosis with ELISA. Sippel, J.E., El-Masry, N.A., Farid, Z. Lancet (1982) [Pubmed]
  9. Cimetidine and brucellosis. Thornes, R.D. Lancet (1982) [Pubmed]
  10. Brucellosis, immunodepression, and levamisole. Renoux, M., Renoux, G. Lancet (1977) [Pubmed]
  11. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ariza, J., Gudiol, F., Pallares, R., Viladrich, P.F., Rufi, G., Corredoira, J., Miravitlles, M.R. Ann. Intern. Med. (1992) [Pubmed]
  12. Divergence in macromolecular assembly: X-ray crystallographic structure analysis of lumazine synthase from Brucella abortus. Braden, B.C., Velikovsky, C.A., Cauerhff, A.A., Polikarpov, I., Goldbaum, F.A. J. Mol. Biol. (2000) [Pubmed]
  13. Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks. Cisneros, J.M., Viciana, P., Colmenero, J., Pachón, J., Martinez, C., Alarcón, A. Antimicrob. Agents Chemother. (1990) [Pubmed]
  14. Efficacy of ciprofloxacin for treatment of Brucella melitensis infections. al-Sibai, M.B., Halim, M.A., el-Shaker, M.M., Khan, B.A., Qadri, S.M. Antimicrob. Agents Chemother. (1992) [Pubmed]
  15. Comparative trial of co-trimoxazole versus tetracycline-streptomycin in treating human brucellosis. Ariza, J., Gudiol, F., Pallarés, R., Rufí, G., Fernández-Viladrich, P. J. Infect. Dis. (1985) [Pubmed]
  16. TNFA promoter polymorphism and susceptibility to brucellosis. Caballero, A., Bravo, M.J., Nieto, A., Colmenero, J.D., Alonso, A., Martín, J. Clin. Exp. Immunol. (2000) [Pubmed]
  17. Occurrence and potential diagnostic applications of serological cross-reactivities between Brucella and other alpha-proteobacteria. Delpino, M.V., Fossati, C.A., Baldi, P.C. Clin. Diagn. Lab. Immunol. (2004) [Pubmed]
  18. Limited diagnostic usefulness of antibodies to cytoplasmic proteins of Brucella in early-treated human brucellosis. Baldi, P.C., Giambartolomei, G.H., Wallach, J.C., Velikovsky, C.A., Fossati, C.A. Scand. J. Infect. Dis. (2001) [Pubmed]
  19. Pharmacotherapeutics of the newer tetracyclines. Aronson, A.L. J. Am. Vet. Med. Assoc. (1980) [Pubmed]
  20. Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice. Doyle, A.G., Halliday, W.J., Barnett, C.J., Dunn, T.L., Hume, D.A. Infect. Immun. (1992) [Pubmed]
  21. Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes. Prior, S., Gander, B., Lecároz, C., Irache, J.M., Gamazo, C. J. Antimicrob. Chemother. (2004) [Pubmed]
  22. Defective interferon-gamma production by T-lymphocytes from patients with acute brucellosis. Rodriguez-Zapata, M., Salmeron, I., Manzano, L., Salmeron, O.J., Prieto, A., Alvarez-Mon, M. Eur. J. Clin. Invest. (1996) [Pubmed]
  23. Effect of the treatment of brucellosis on leukocyte superoxide dismutase activity and plasma nitric oxide level. Karabulut, A.B., Sonmez, E., Bayindir, Y. Ann. Clin. Biochem. (2005) [Pubmed]
  24. Protective effect of doxycycline use on coronary artery disease? Kardara, M., Papazafiropoulou, A., Katsakiori, P., Petropoulos, C., Jelastopulu, E. J. Infect. (2006) [Pubmed]
  25. Increased serum levels of interferon-gamma and interleukin-12 during human brucellosis. Ahmed, K., Al-Matrouk, K.A., Martinez, G., Oishi, K., Rotimi, V.O., Nagatake, T. Am. J. Trop. Med. Hyg. (1999) [Pubmed]
  26. Polymorphisms of the interferon gamma and interleukin 10 genes in human brucellosis. Bravo, M.J., de Dios Colmenero, J., Alonso, A., Caballero, A. Eur. J. Immunogenet. (2003) [Pubmed]
  27. Serum cytokine levels in patients with acute brucellosis and their relation to the traditional inflammatory markers. Demirdag, K., Ozden, M., Kalkan, A., Godekmerdan, A., Sirri Kilic, S. FEMS Immunol. Med. Microbiol. (2003) [Pubmed]
  28. Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection. Baldwin, C.L., Parent, M. Vet. Microbiol. (2002) [Pubmed]
  29. Antibody response to antigens distinct from smooth lipopolysaccharide complex in Brucella infection. Schurig, G.G., Jones, L.M., Speth, S.L., Berman, D.T. Infect. Immun. (1978) [Pubmed]
  30. Enzyme-linked immunosorbent assay with major outer membrane proteins of Brucella melitensis to measure immune response to Brucella species. Hunter, S.B., Bibb, W.F., Shih, C.N., Kaufmann, A.F., Mitchell, J.R., McKinney, R.M. J. Clin. Microbiol. (1986) [Pubmed]
  31. 2-mercaptoethanol Brucella agglutination test: usefulness for predicting recovery from brucellosis. Buchanan, T.M., Faber, L.C. J. Clin. Microbiol. (1980) [Pubmed]
  32. Treatment of human brucellosis with netilmicin and doxycycline. Solera, J., Espinosa, A., Geijo, P., Martínez-Alfaro, E., Sáez, L., Sepúlveda, M.A., Ruiz-Ribó, M.D. Clin. Infect. Dis. (1996) [Pubmed]
  33. Cloning of Brucella abortus gene and characterization of expressed 26-kilodalton periplasmic protein: potential use for diagnosis. Rossetti, O.L., Arese, A.I., Boschiroli, M.L., Cravero, S.L. J. Clin. Microbiol. (1996) [Pubmed]
WikiGenes - Universities